SCHEMBL10241330

SCHEMBL10241330

Cc1cc(/C(C[C@@H](c2ccccc2)c2ccc(Cl)cc2C)=N/O)ccn1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPBAR1 Q8TDU6 6/20 0.63
SCN4A P35499 3/20 0.36
PROKR1 Q8TCW9 1/20 0.35
LMNA P02545 3/20 0.34
MAPT P10636 2/20 0.34
HTT P42858 2/20 0.34
HPGD P15428 2/20 0.34
CRHBP P24387 1/20 0.34
MAPK1 P28482 1/20 0.34
CRHR2 Q13324 1/20 0.34
ALPL P05186 1/20 0.34
ALOX12 P18054 1/20 0.34
CYP1A2 P05177 1/20 0.33
CYP3A4 P08684 1/20 0.33
CYP2D6 P10635 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2C19 P33261 1/20 0.33
NPSR1 Q6W5P4 1/20 0.33
NR3C2 P08235 1/20 0.32
SLC6A4 P31645 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1389907 1.00 GPBAR1 (0.63) GPBAR1SCN4APROKR1LMNAMAPT
SCHEMBL364469 1.00 GPBAR1 (0.63) GPBAR1SCN4APROKR1LMNAMAPT
SCHEMBL1389908 1.00 GPBAR1 (0.63) GPBAR1SCN4APROKR1LMNAMAPT
SCHEMBL10290855 0.93 GPBAR1 (0.59) GPBAR1PROKR1LMNAMAPTMEN1
SCHEMBL1389651 0.92 GPBAR1 (0.58) GPBAR1PROKR1MAPTMAPK1MEN1
SCHEMBL363466 0.92 GPBAR1 (0.58) GPBAR1PROKR1MAPTMAPK1MEN1
SCHEMBL1389653 0.92 GPBAR1 (0.58) GPBAR1PROKR1MAPTMAPK1MEN1
SCHEMBL364545 0.92 GPBAR1 (0.58) GPBAR1PROKR1MAPTMAPK1MEN1
SCHEMBL363424 0.91 GPBAR1 (0.57) GPBAR1PROKR1KMT2A
SCHEMBL1389709 0.91 GPBAR1 (0.57) GPBAR1PROKR1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593426-B1 1-HYDROXYIMINO-3-PHENYL-PROPANES HOFFMANN LA ROCHE (CH) 2014-08-20 EP disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
US-8765730-B2 1-hydroxyimino-3-phenyl-propanes Hoffmann-La Roche Inc (US) 2014-07-01 US disclosed
WO-2012007365-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-19 WO disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES F. HOFFMANN-LA ROCHE AG (CH) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010190-A1 1-HYDROXYIMINO-3-PHENYL-PROPANES GPBAR1, GPR119, ADRB1 GPBAR1 1/4885SCN4A 1200/4885PROKR1 242/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.